Cargando…
Stochastic cost-effectiveness analysis on population benefits
Dealing with randomness is a crucial aspect that cost-effectiveness analysis (CEA) tools need to address, but existing stochastic CEA tools have rarely examined risk and return from the perspective of population benefits, concerning the benefits of a group of individuals but not just a typical one....
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605454/ https://www.ncbi.nlm.nih.gov/pubmed/37884980 http://dx.doi.org/10.1186/s12962-023-00488-y |
_version_ | 1785127077758894080 |
---|---|
author | Chen, Ermo |
author_facet | Chen, Ermo |
author_sort | Chen, Ermo |
collection | PubMed |
description | Dealing with randomness is a crucial aspect that cost-effectiveness analysis (CEA) tools need to address, but existing stochastic CEA tools have rarely examined risk and return from the perspective of population benefits, concerning the benefits of a group of individuals but not just a typical one. This paper proposes a stochastic CEA tool that supports medical decision-making from the perspective of population benefits of risk and return, the risk-adjusted incremental cost-effectiveness ratio (ICER). The tool has a traditional form of ICER but uses the cost under a risk-adjusted expectation. Theoretically, we prove that the tool can provide medical decisions trimming that promote the risk-return level on population benefits within any intervention structure and can also serve as a criterion for the optimal intervention structure. Numerical simulations within a framework of mean–variance support the conclusions in this paper. |
format | Online Article Text |
id | pubmed-10605454 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-106054542023-10-28 Stochastic cost-effectiveness analysis on population benefits Chen, Ermo Cost Eff Resour Alloc Methodology Dealing with randomness is a crucial aspect that cost-effectiveness analysis (CEA) tools need to address, but existing stochastic CEA tools have rarely examined risk and return from the perspective of population benefits, concerning the benefits of a group of individuals but not just a typical one. This paper proposes a stochastic CEA tool that supports medical decision-making from the perspective of population benefits of risk and return, the risk-adjusted incremental cost-effectiveness ratio (ICER). The tool has a traditional form of ICER but uses the cost under a risk-adjusted expectation. Theoretically, we prove that the tool can provide medical decisions trimming that promote the risk-return level on population benefits within any intervention structure and can also serve as a criterion for the optimal intervention structure. Numerical simulations within a framework of mean–variance support the conclusions in this paper. BioMed Central 2023-10-26 /pmc/articles/PMC10605454/ /pubmed/37884980 http://dx.doi.org/10.1186/s12962-023-00488-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Methodology Chen, Ermo Stochastic cost-effectiveness analysis on population benefits |
title | Stochastic cost-effectiveness analysis on population benefits |
title_full | Stochastic cost-effectiveness analysis on population benefits |
title_fullStr | Stochastic cost-effectiveness analysis on population benefits |
title_full_unstemmed | Stochastic cost-effectiveness analysis on population benefits |
title_short | Stochastic cost-effectiveness analysis on population benefits |
title_sort | stochastic cost-effectiveness analysis on population benefits |
topic | Methodology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605454/ https://www.ncbi.nlm.nih.gov/pubmed/37884980 http://dx.doi.org/10.1186/s12962-023-00488-y |
work_keys_str_mv | AT chenermo stochasticcosteffectivenessanalysisonpopulationbenefits |